Norovirus P Particle as a Platform for Antigen Presentation

Procedia in Vaccinology

Volumn 4, Issue , 2011, Pages 19-26

  Tan, Ming ^a,b   Xia, Ming ^a   Huang, Pengwei ^a   Wang, Leyi ^a   Zhong, Weiming ^a   McNeal, Monica ^a,b   Wei, Chao ^a   Jiang, Xi ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Antigen presentation; Calicivirus; Influenza virus vaccine; Norovirus; P particle; Rotavirus vaccine; Vaccine platform

Indexed keywords

BLOOD GROUP ANTIGEN; IMMUNOLOGICAL ADJUVANT; VIRUS LIKE PARTICLE VACCINE; VIRUS RECEPTOR; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG INHIBITION; IMMUNE RESPONSE; INFLUENZA VIRUS; MOUSE; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; ROTAVIRUS; VIRUS INFECTION;

EID: 80053400176     PISSN: None     EISSN: 1877282X     Source Type: Journal    
DOI: 10.1016/j.provac.2011.07.004     Document Type: Article

References (45)

1. Dragnea B., Chen C., Kwak E.S., Stein B., Kao C.C. Gold nanoparticles as spectroscopic enhancers for in vitro studies on single viruses. J Am Chem Soc 2003, 125:6374-6375.
2. Douglas T., Young M., Viruses: making friends with old foes. Science 2006, 312:873-875.
3. Douglas T., Materials science. A bright bio-inspired future. Science 2003, 299:1192-1193.
4. Peabody D.S. A Viral Platform for Chemical Modification and Multivalent Display. J Nanobiotechnology 2003, 1:5.
5. Chen C., Daniel M.C., Quinkert Z.T., De M., Stein B., Bowman V.D., et al. Nanoparticle-templated assembly of viral protein cages. Nano Lett 2006, 6:611-615.
6. Chen C., Kwak E.S., Stein B., Kao C.C., Dragnea B. Packaging of gold particles in viral capsids. J Nanosci Nanotechnol 2005, 5:2029-2033.
7. Radloff C., Vaia R.A., Brunton J., Bouwer G.T., Ward V.K. Metal nanoshell assembly on a virus bioscaffold. Nano Lett 2005, 5:1187-1191.
8. Ochoa W.F., Chatterji A., Lin T., Johnson J.E. Generation and structural analysis of reactive empty particles derived from an icosahedral virus. Chem Biol 2006, 13:771-778.
9. Manayani D.J., Thomas D., Dryden K.A., Reddy V., Siladi M.E., Marlett J.M., et al. A viral nanoparticle with dual function as an anthrax antitoxin and vaccine. PLoS Pathog 2007, 3:e142.
10. Kratz P.A., Bottcher B., Nassal M. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci U S A 1999, 96:1915-1920.
11. Nassal M., Skamel C., Kratz P.A., Wallich R., Stehle T., Simon M.M. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Eur J Immunol 2005, 35:655-665.
12. Siebenga J.J., Vennema H., Duizer E., Koopmans M.P. Gastroenteritis caused by norovirus GGII.4. The Netherlands, 1994-2005. Emerg Infect Dis 2007, 13:144-146.
13. Lin TaJ J. Structures of Picorna-like plant viruses: implications and applications. Advances in virus research 2003, 62:167-239.
14. Johnson J., Lin T., Lomonossoff G. Presentation of heterologous peptides on plant viruses: genetics, structure, and function. Annu Rev Phytopathol 1997, 35:67-86.
15. Lomonossoff G.P., Johnson J.E. Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines. Curr Opin Struct Biol 1996, 6:176-182.
16. Porta C., Spall V.E., Lin T., Johnson J.E., Lomonossoff G.P. The development of cowpea mosaic virus as a potential source of novel vaccines. Intervirology 1996, 39:79-84.
17. Porta C., Spall V.E., Loveland J., Johnson J.E., Barker P.J., Lomonossoff G.P. Development of cowpea mosaic virus as a highyielding system for the presentation of foreign peptides. Virology 1994, 202:949-955.
18. Chatterji A., Burns L.L., Taylor S.S., Lomonossoff G.P., Johnson J.E., Lin T., et al. Cowpea mosaic virus: from the presentation of antigenic peptides to the display of active biomaterials. Intervirology 2002, 45:362-370.
19. Chatterji A., Ochoa W., Shamieh L., Salakian S.P., Wong S.M., Clinton G., et al. Chemical conjugation of heterologous proteins on the surface of Cowpea mosaic virus. Bioconjug Chem 2004, 15:807-813.
20. Taylor K.M., Lin T., Porta C., Mosser A.G., Giesing H.A., Lomonossoff G.P., et al. Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus. J Mol Recognit 2000, 13:71-82.
21. Tan M., Fang P., Chachiyo T., Xia M., Huang P., Fang Z., Noroviral P, et al. particle: Structure, function and applications in virus-host interaction. Virology 2008, 382:115-123.
22. Tan M., Jiang X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. Journal of Virology 2005, 79:14017-14030.
23. Tan M., Huang P., Xia M., Fang P.A., Zhong W., McNeal M., Norovirus P, et al. particle, a novel platform for vaccine development and antibody production. J Virol 2011, 85:753-764.
24. Prasad B.V., Hardy M.E., Dokland T., Bella J., Rossmann M.G., Estes M.K. X-ray crystallographic structure of the Norwalk virus capsid. Science 1999, 286:287-290.
25. Bertolotti-Ciarlet A., White L.J., Chen R., Prasad B.V., Estes M.K. Structural requirements for the assembly of Norwalk viruslike particles. J Virol 2002, 76:4044-4055.
26. Tan M., Hegde R.S., Jiang X., The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol 2004, 78:6233-6242.
27. Bu W., Mamedova A., Tan M., Xia M., Jiang X., Hegde R.S. Structural basis for the receptor binding specificity of Norwalk virus. J Virol 2008, 82:5340-5347.
28. Cao S., Lou Z., Tan M., Chen Y., Liu Y., Zhang Z., et al. Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol 2007, 81:5949-5957.
29. Tan M., Meller J., Jiang X. C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. Journal of Virology 2006, 80:7322-7331.
30. Tan M., Fang P.A., Xia M., Chachiyo T., Jiang W., Jiang X. Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles. Virology 2011, 410:345-352.
31. Tan M., Jin M., Xie H., Duan Z., Jiang X., Fang Z. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol 2008, 80:1296-1301.
32. Tan M., Xia M., Cao S., Huang P., Farkas T., Meller J., et al. Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology 2008, 379:324-334.
33. Tan M., Xia M., Chen Y., Bu W., Hegde R.S., Meller J., et al. Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS One 2009, 4:e5058.
34. Jiang X, Tan M, inventors; Norovirus P particles as a carrier for presentation of foreign antigens and other molecules. US Patent application number: 61185564. 2009.
35. Tan M., Huang P., Xia M., Fang P., Zhong W., Wei C., Norovirus P, et al. particle, a multifunctional vaccine platform. J Virol 2011, 85:753-764.
36. Tan M., Jiang X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol 2005, 79:14017-14030.
37. Curnis F., Arrigoni G., Sacchi A., Fischetti L., Arap W., Pasqualini R., et al. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res 2002, 62:867-874.
38. Maeshima Y., Colorado P.C., Kalluri R. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 2000, 275:23745-23750.
39. Worgall S., Krause A., Qiu J., Joh J., Hackett N.R., Crystal R.G. Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF. J Virol 2007, 81:13801-13808.
40. Choi A.H., Basu M., McNeal M.M., Flint J., VanCott J.L., Clements J.D., et al. Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J Virol 2000, 74:11574-11580.
41. Tan M., Jiang X. Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol 2005, 13:285-293.
42. Tan M., Jiang X. Norovirus-host interaction: implications for disease control and prevention. Expert Rev Mol Med 2007, 9:1-22.
43. Tan M., Jiang X., Norovirus gastroenteritis carbohydrate receptors, and animal models. PLoS Pathog 2010, 6:e1000983.
44. Tan M., Zhong W., Song D., Thornton S., Jiang X. E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. J Med Virol 2004, 74:641-649.
45. Huang P., Farkas T., Zhong W., Tan M., Thornton S., Morrow A.L., et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 2005, 79:6714-6722.